摘要
目的探讨注射用头孢哌酮舒巴坦钠联合综合护理干预对重症监护病房(ICU)危重患者抗感染的疗效。方法选择2015年3月至2017年3月ICU收治的危重患者80例,采用随机抽签分类法将患者分为对照组和研究组,各40例。对照组患者给予左氧氟沙星注射液联合常规护理干预,研究组患者给予注射用头孢哌酮舒巴坦钠联合综合护理干预。结果与对照组比较,研究组患者的疗效及相关指标改善情况更好,药品不良反应发生率和肺内感染率更低,住院时间、ICU治疗时间及机械通气时间更短(P<0.05)。结论注射用头孢哌酮舒巴坦钠联合综合护理干预ICU危重症患者,疗效显著,药品不良反应发生率和肺内感染率较低,值得临床推广。
Objective To investigate the clinical efficacy of Cefoperazone Sodium and Sulbactam Sodium for Injection combined with comprehensive nursing intervention for treating critically ill patients in ICU. Methods Totally 80 critically ill patients in ICU from March 2015 to March 2017 were selected and divided into the control group and the study group by random sampling method, 40 cases in each group. The control group was given Levofloxacin Injection combined with routine nursing intervention, while the study group was treated with Cefoperazone Sodium and Sulbactam Sodium for Injection combined with comprehensive nursing intervention. Results Compared with the control group, the efficacy and related indexes of the study group improved better, the incidence rate of adverse drug reactions and pulmonary infection were lower, the hospitalization time, ICU treatment time and mechanical ventilation time were shorter （ P 〈 0. 05 ） . Conclusion Cefoperazone Sodium and Sulbactam Sodium for Injection combined with comprehensive nursing intervention for treating critically ill patients in ICU has significant curative effect, low incidence of adverse drug reactions and pulmonary infection, it is worthy of clinical promotion.
出处
《中国药业》
CAS
2017年第23期59-61,共3页
China Pharmaceuticals
关键词
头孢哌酮舒巴坦钠
危重症患者
抗感染
疗效
cefoperazone sodium and sulbactam sodium
critically ill patients
anti-infection
curative effect
